Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) investors have a smile on their faces Tuesday morning, after the drug maker announced the receipt of official minutes from …
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares climbed nearly 12% this morning, after the drug maker announced the successful synthesis of a potential smallpox-preventing …
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that it intends to offer and sell, subject to market and other conditions, shares of its common …
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has been left to discontinue its program for fibromyalgia-treating pipeline drug Tonmya in the wake of phase 3 …
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced preliminary topline results from its Phase 3 clinical study, AFFIRM, designed to evaluate the safety and efficacy of …
Late this past Friday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) came in with numbers for its second quarter, posting a loss of ($0.
Analysts weighed in with favorable reports on pharmaceutical companies Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP).
While shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) keep tumbling following results from the company’s Phase 2 clinical study in patients with military-related PTSD, Oppenheimer analyst …
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were on a roller-coaster ride today after the drug maker announced data from its Phase 2 trial in Post Traumatic Stress …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
